Autophagy and Tumorigenesis
Open Access
- 30 June 2010
- journal article
- review article
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 32 (4) , 383-396
- https://doi.org/10.1007/s00281-010-0213-0
Abstract
Autophagy, a catabolic process involved in the sequestration and lysosomal degradation of cytoplasmic contents, is crucial for cellular homeostasis. The current literature supports that autophagy plays diverse roles in the development, maintenance, and progression of tumors. While genetic evidence indicates autophagy functions as a tumor suppressor mechanism, it is also apparent that autophagy can promote the survival of established tumors under stress conditions and in response to chemotherapy. In this review, we discuss the mechanisms and the evidence underlying these multifaceted roles of autophagy in tumorigenesis, the prospects for targeting autophagy in cancer therapy, and overview the potential markers that may be utilized to reliably detect autophagy in clinical settings.Keywords
This publication has 118 references indexed in Scilit:
- TOR-dependent control of autophagy: biting the hand that feedsCurrent Opinion in Cell Biology, 2009
- mTOR and cancer: many loops in one pathwayCurrent Opinion in Cell Biology, 2009
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma CellsCancer Cell, 2009
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR SignalingCell, 2008
- A Molecule Targeting VHL-Deficient Renal Cell Carcinoma that Induces AutophagyCancer Cell, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Immune cells as mediators of solid tumor metastasisCancer and Metastasis Reviews, 2007
- Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisPublished by Elsevier ,2006
- Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor inductionCancer Cell, 2004
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002